Dilek Telci

1.6k total citations
58 papers, 1.2k citations indexed

About

Dilek Telci is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Dilek Telci has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Pulmonary and Respiratory Medicine and 11 papers in Biomaterials. Recurrent topics in Dilek Telci's work include RNA Interference and Gene Delivery (16 papers), Blood properties and coagulation (13 papers) and Nanoparticle-Based Drug Delivery (11 papers). Dilek Telci is often cited by papers focused on RNA Interference and Gene Delivery (16 papers), Blood properties and coagulation (13 papers) and Nanoparticle-Based Drug Delivery (11 papers). Dilek Telci collaborates with scholars based in Türkiye, United Kingdom and United States. Dilek Telci's co-authors include Martin Griffin, Fikrettin Şahιn, Zejing Wang, Elisabetta Verderio, Hüveyda Başağa, Afam A. Okoye, Gerry Melino, Polen Koçak, Özgür Yılmaz and Manuela Baccarini and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Dilek Telci

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dilek Telci Türkiye 19 529 383 141 124 120 58 1.2k
Dongqing Zuo China 21 274 0.5× 787 2.1× 54 0.4× 103 0.8× 55 0.5× 45 1.6k
Akiva Vexler Israel 22 167 0.3× 632 1.7× 69 0.5× 144 1.2× 265 2.2× 53 1.6k
Peter M. Kanter United States 21 195 0.4× 620 1.6× 50 0.4× 108 0.9× 46 0.4× 48 1.4k
Wenjun Wang China 24 224 0.4× 828 2.2× 83 0.6× 126 1.0× 83 0.7× 70 2.0k
Guo Chen China 22 204 0.4× 779 2.0× 111 0.8× 45 0.4× 54 0.5× 108 1.5k
Laura Roncuzzi Italy 17 119 0.2× 984 2.6× 74 0.5× 55 0.4× 83 0.7× 45 1.5k
Xiaoying Zhou China 23 139 0.3× 555 1.4× 157 1.1× 35 0.3× 20 0.2× 62 2.5k
Jin Tao China 24 352 0.7× 910 2.4× 81 0.6× 128 1.0× 21 0.2× 52 1.9k
Bin Zhu China 27 321 0.6× 1.8k 4.8× 160 1.1× 111 0.9× 37 0.3× 82 2.7k
Chunli Yan United States 19 178 0.3× 659 1.7× 72 0.5× 36 0.3× 27 0.2× 25 1.4k

Countries citing papers authored by Dilek Telci

Since Specialization
Citations

This map shows the geographic impact of Dilek Telci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilek Telci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilek Telci more than expected).

Fields of papers citing papers by Dilek Telci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilek Telci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilek Telci. The network helps show where Dilek Telci may publish in the future.

Co-authorship network of co-authors of Dilek Telci

This figure shows the co-authorship network connecting the top 25 collaborators of Dilek Telci. A scholar is included among the top collaborators of Dilek Telci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilek Telci. Dilek Telci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zemheri, Ebru, et al.. (2025). Anticancer Activity of Soy Lecithin‐Based Curcumin in Prostate Cancer. Journal of Applied Polymer Science. 142(18). 3 indexed citations
2.
Nıkerel, Emrah, et al.. (2025). Role of Rs228648 and Rs2890565 single nucleotide polymorphisms in Urotensin-2 gene in prostate cancer. Molecular Biology Reports. 52(1). 572–572.
3.
Şahιn, Fikrettin, et al.. (2025). Effect of enzymatic and non-enzymatic isolation methods on the differentiation potential of endometrial mesenchymal stem cells. Gene. 962. 149569–149569. 1 indexed citations
4.
5.
Yelekçi, Kemal, et al.. (2023). Synthesis and investigation of cytotoxic effects of compounds derived from flurbiprofen. Journal of Molecular Structure. 1289. 135876–135876. 1 indexed citations
6.
Öztürk, Naile, Polen Koçak, Ebru Zemheri, et al.. (2023). Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI30%-b-PCL polymeric micelle nanocarriers. Amino Acids. 55(8). 1023–1037. 4 indexed citations
7.
Yerlikaya, Pınar Obakan, et al.. (2021). Palbociclib negatively regulates fatty acid synthesis due to upregulation of AMPKα and miR‐33a levels to increase apoptosis in Panc‐1 and MiaPaCa‐2 cells. Biotechnology and Applied Biochemistry. 69(1). 342–354. 9 indexed citations
8.
Özçubukçu, Salih, et al.. (2021). Synthesis and evaluation of tumor-homing peptides for targeting prostate cancer. Amino Acids. 53(5). 645–652. 10 indexed citations
9.
Koçak, Polen, Ongun Mehmet Saka, Burcu Devrim, et al.. (2020). Synthesis, biocompatibility and gene encapsulation of poly(2-Ethyl 2-Oxazoline)-dioleoyl phosphatidylethanolamine (PEtOx-DOPE) and post-modifications with peptides and fluorescent dye coumarin. International Journal of Polymeric Materials. 70(14). 981–993. 14 indexed citations
10.
Koçak, Polen, Mehmet Atilla Taşdelen, Özgür Yılmaz, et al.. (2020). The Utilization of Poly(2‐ethyl‐2‐oxazoline)‐b‐Poly(ε‐caprolactone) Ellipsoidal Particles for Intracellular BIKDDA Delivery to Prostate Cancer. Macromolecular Bioscience. 21(2). e2000287–e2000287. 3 indexed citations
11.
Nıkerel, Emrah, et al.. (2020). Association of 5′UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis. Gene. 742. 144589–144589. 10 indexed citations
12.
Yerlikaya, Pınar Obakan, et al.. (2019). Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial‐mesenchymal transition in Panc‐1 and MiaPaCa‐2 pancreatic cancer cells. Journal of Cellular Biochemistry. 121(1). 508–523. 22 indexed citations
13.
Zemheri, Ebru, et al.. (2019). Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma In Vitro and In Vivo. Journal of Cancer. 10(6). 1466–1478. 23 indexed citations
14.
Demirci, Selami, Ayşegül Doğan, Dilek Telci, et al.. (2017). Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo. Anti-Cancer Drugs. 28(8). 869–879. 7 indexed citations
15.
Demirci, Selami, Ayşegül Doğan, Neşe Başak, et al.. (2015). A Schiff base derivative for effective treatment of diethylnitrosamine-induced liver cancer in vivo. Anti-Cancer Drugs. 26(5). 555–564. 22 indexed citations
16.
Ayşan, Erhan, et al.. (2013). Cancer Preventive Effects of Whole Cell Type Immunization against Mice Ehrlich Tumors. Asian Pacific Journal of Cancer Prevention. 14(6). 3515–3519. 3 indexed citations
17.
Telci, Dilek, Emin Özbek, Emre Can Polat, et al.. (2011). <i>KLOTHO</i> Gene Polymorphism of G395A Is Associated with Kidney Stones. American Journal of Nephrology. 33(4). 337–343. 35 indexed citations
18.
Tanrıverdi, Orhan, Dilek Telci, Mustafa Aydın, et al.. (2011). Hyperoxaluria-induced tubular ischemia: the effects of verapamil and vitamin E on apoptotic changes with an emphasis on renal papilla in rat model. Urological Research. 40(1). 17–25. 7 indexed citations
19.
Wang, Zejing, Russell Collighan, Stephane R. Gross, et al.. (2010). RGD-independent Cell Adhesion via a Tissue Transglutaminase-Fibronectin Matrix Promotes Fibronectin Fibril Deposition and Requires Syndecan-4/2 and α5β1 Integrin Co-signaling. Journal of Biological Chemistry. 285(51). 40212–40229. 73 indexed citations
20.
Arısan, Elif Damla, Özgür Kütük, Tuğsan Tezil, et al.. (2009). Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells. Breast Cancer Research and Treatment. 119(2). 271–281. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongqing Zuo Breakdown of academic impact, for papers by Akiva Vexler Breakdown of academic impact, for papers by Peter M. Kanter Breakdown of academic impact, for papers by Wenjun Wang Breakdown of academic impact, for papers by Guo Chen Breakdown of academic impact, for papers by Laura Roncuzzi Breakdown of academic impact, for papers by Xiaoying Zhou Breakdown of academic impact, for papers by Jin Tao Breakdown of academic impact, for papers by Bin Zhu Breakdown of academic impact, for papers by Chunli Yan
Rankless by CCL
2026